Printer Friendly

Comparison of the Protective Effects of Calendula officinalis Extract and Hyaluronic Acid Anti-adhesion Barrier against Postoperative Intestinal Adhesion Formation in Rats/Ratlarda Postoperatif intestinal Adezyon Formasyonuna karsi Calendula officinalis Extraktinin ve Hyaluronik Asit Anti-adezyon Barierinin Koruyucu Etkilerinin Karsilastirilmasi.

Introduction

Despite advances in the surgical techniques and instruments used, postoperative adhesions are unpredictable consequences of laparotomies. Postoperative intraabdominal adhesion formation remains an important cause of morbidity and mortality. The reported incidence of adhesions in patients after laparotomy ranges from 32.6% to 90%. (1,2) While some of these patients have no complaints, a significant proportion will develop small bowel obstruction, bowel infarction, pain, constipation, or infertility in women. (3) The time required for treatment results in a loss of labour, and the costs of treatment constitute an economic loss. (4) Several agents and barrier systems have been developed to reduce the incidence of adhesions, but none is 100% effective. The hyaluronic acid containing adhesion barrier (HAAB) is widely used worldwide. (5) Although HAAB significantly reduced the formation of adhesions in some animal studies and clinical trials, it does not completely inhibit the formation of adhesions.

Calendula officinalis extract (COE) is an herbal agent that has anti-inflammatory, anti-oedema, and antimicrobial activities experimentally and clinically, and it is used traditionally in many parts of the world for healing wounds, peptic ulcers, and venous ulcers in the feet and legs of diabetics, preventing skin ulcers caused by radiotherapy for breast cancer, and improving colitis in inflammatory bowel disease. It was effective in the treatment of experimental oral mucositis in hamsters and in the treatment of second and third degree burns in ra ts. (6,7,8,9,10,11,12,13,14,15,16,17,18,19) Long-term studies have shown that the acute and chronic toxicity of oral COE is very low in female and male rats and rarely leads to anaphylactic reactions, uterotonic effects in pregnancies, hypotension, or sedation. (20,21,22,23) The efficacy of COE in the treatment of many different pathological conditions has been demonstrated experimentally and clinically. However, few studies have examined the anti-adhesion activity of COE. Therefore, this study investigated the efficacy of COE in preventing postoperative intra-abdominal adhesions and compared it with the anti-adhesive efficacy of HAAB.

Materials and Methods

This study was conducted in the Animal Research Laboratory of Kahramanmaras Sutcu Imam University after obtaining permission from the Ethics Committee. Thirty 10-12-week-old male Wistar Albino rats, each weighing 300-350 grams, were used. The animals were divided into three groups of 10 rats each. In group 1 (control group) only the scraping model was applied. In group 2, the scraping model was applied, and then HAAB was applied to the abraded bowel. Similarly, group 3 was subjected to scraping, and then the COE was applied. We used two gel preparations of The HAAB (Heine Medizin Adhesion Barrier Gel) (Figures 1, 2). The COE was obtained from the leaves of marigold plants (Calendula officinalis). Since a pure extract could not be obtained, it was obtained in a 4/3 ratio of pure olive oil to COE from an herbalist in Italy. A detailed biochemical analysis could not be performed. We also have no information on the altitude or region in Italy where the marigolds were grown. The rats were anaesthetised with 50 mg/kg ketamine hydrochloride (Ketalar, 50 mg/mL; intramuscular; Parke-Davis, Istanbul, Turkey) and 5 mg/kg xylazine (Xylazine-20 injection; Butler, Columbus, OH, USA).

A 3 cm midline incision was made after disinfecting the animal's abdominal skin with povidone iodide. The terminal ileum and cecum were held in a wet sponge and mobilised. Both sides of a 5~10 cm segment of the terminal ileum and cecum were irritated with a sponge until a pellet formed on the serosal surface. The scraped segment was clamped for 1 minute to create arterial transient ischemia (scraping model, Figure 3). The control group was subjected to scraping only. The scraped area was covered with 3 mL of COE in the COE group or 1 mL of adhesion barrier in the HAAB group. The abdominal incisions were closed with two layers of continuous 3/0 silk sutures. All rats were allowed to feed daily until they were sacrificed 15 days postoperatively. After sacrifice, an inverted U-shaped incision was made in the anterior abdominal wall to allow maximal exposure of the abdominal cavity. The adhesions were examined macroscopically by three independent investigators (A.E., A.I., and A.N.S.) and rated using the Blauer and Collins scale (Table 1). Adhesion-containing tissue samples were excised and fixed in 10% formaldehyde solution. The samples were embedded in paraffin and dehydrated. Then, 5 pm cross sections were prepared with a microtome. After staining with haematoxylin eosin, the samples were examined by the same pathologist (A.Y.B.) under light microscopy for their general structure, amount of fibroblast activity, and presence of fibrosis (Table 2). A fibrosis score for each rat was calculated according to these criteria.

Statistical Analysis

SPSS 22.0 (IBM, Armonk, NY, USA) was used to analyse the data. The Kruskal-Wallis H-test was used for the nonparametric tests with the Monte Carlo simulation technique, and Dunn's test was used for the post hoc analyses. Quantitative variables are shown as the median (range), and categorical variables as a number. Variables were examined at the 95% confidence level, and a p value <0.05 was considered significant.

Results

All 30 rats survived until the repeat laparotomy. Table 1 shows the Blauer and Collins macroscopic adhesion scores.

Grade 4 adhesions were seen only in three rats in the control group. The adhesions were grade 0-4 in 0, 4, 2, 1, and 3 rats in the control group, 3, 3, 1, 3, and 0 rats in the HAAB group, and 2, 3, 3, 2, and 0 rats in the COE group, respectively. There were no differences in the Blauer and Collins scores among the groups (Table 2; Figure 4). Table 3 summarises the results of the histopathological examinations in terms of the general structure of the adhesions, amount of fibroblast activity, and presence of fibrosis. Respective microscopic adhesion assessment scores of 0 to 3 were seen in 2, 4, 4, and 0 rats in the control group, 0, 6, 3, and 1 rats in the HAAB group, and 5, 4, 1, and 0 rats in the COE group (Figures 5, 6, 7). Histopathologically, the fibrolipomatous tissue of the adherent areas of rats in the control group showed a decrease in fat tissue, with moderate fibrosis and fibroblast accumulation and a moderate mixed infiltration of lymphocytes, plasma cells, and polymorphonuclear leukocytes (Figure 7). The density of inflammatory cells and fibroblasts was decreased in the HAAB and COE groups (Figure 5). Comparison of the microscopic adhesion scores based on the histopathological examination revealed significant differences between groups 1 and 2 (p=0.044) and between groups 1 and 3 (p=0.010), but not between groups 2 and 3 (p=1). Group 1 had the highest score for adhesions between the abdominal wall and intra-abdominal organs (Table 2). COE and HAAB significantly reduced the incidence of intra-abdominal peritoneal adhesions in scraping-model rats when compared with the control group (Graph 1).

Discussion

Although the mechanism is not clear, COE administered in the peritoneal cavity significantly reduced the development of adhesions. There was no statistical difference between COE and HAAB at preventing adhesions. COE is less expensive than HAAB. Although no adverse effects were seen in the rats treated with COE, toxicology studies must be performed before it is administered to humans. In addition, studies should examine the effects of higher doses of COE on its efficacy and toxicity. The rate of obstruction caused by abdominal surgery-induced adhesions ranges from 92.9% to 100% (24,25) of which 60~70% are small bowel obstructions. (25) The relaparotomy rate due to obstruction is 29~50%. (26,27) Other adverse effects of adhesions include enterocutaneous fistulas, intra-abdominal abscesses, chronic abdominal pain, and infertility in females due to perforations caused by intestinal obstruction. (28,29) The prolonged hospital stays and loss of labour are other important problems. Recurrent relaparotomy is also a major cause of mortality. (28) Although there is now a fairly good understanding of how and why adhesions occur, and there are agents to reduce adhesion formation, no agent completely prevents adhesions. Foreign bodies, blood, tissue ischemia, infection, and some chemicals that cause irritation and damage the peritoneum are all responsible for the formation of adhesions. (30,31) There are many models of the formation of adhesions in experimental animals, including caecal scraping, caecal abrasion, uterine adhesion, peritonitis, and peritoneal defect models. (32,33,34,35,36) We chose a scraping model that involved both ischemic and peritoneal injury (Figure 3) because ischemia and peritoneal damage frequently occur during abdominal surgery in humans. After abdominal surgery, adhesions form in an average of 7-10 days, and fibrosis with the formation of fibrotic bands occurs in 14 days. Therefore, we waited 15 days to perform the relaparotomies. There is no globally accepted scoring system for adhesions. Rather, different scoring systems are based on various parameters such as thickness, type, vascularisation, adhesiveness, density, and fibroblast density of the adhesions. The Mazuji adhesion scale ranges from 0 to 5, the Moreno score from 2 to 7, the Bigatti score from 0 to 11, and the Blauer and Collins (38) score from 0 to 4. (37,38) We chose the scoring system of Blauer and Collins, which is used widely and is useful for assessing macroscopic and microscopic adhesions. Various agents have been used to prevent postoperative adhesions, including corticosteroids, antihistamines, dextran, saline, anti-cytokine agents, a recombinant tissue plasminogen activator, aprotinin, octreotide, heparin, and biorefined membranes modified from carboxymethyl cellulose, oxidised regenerated cellulose, polyethylene glycol, expanded polytetrafluoroethylene, and hyaluronic acid. However, no agent or system completely inhibits adhesions. (39,40) Currently, hyaluronic acid preparations are among the most widely used. In this study, we compared the efficacy of HAAB at preventing postoperative intra-abdominal adhesions with that of COE, which has antimicrobial, anti-oedema, and anti-inflammatory activities. The results showed that intraperitoneal COE and HAAB both significantly reduced the development of adhesions compared with the control group. There was no difference in the inhibitory effect of the two agents. None of the rats died before the end of the experiment, suggesting that both agents were reliable in the quantities used. However, we cannot predict the effects of applying COE in different quantities. In our study, the use of HAAB within the peritoneal cavity gave results similar to those obtained in many previous studies, further demonstrating its efficacy in preventing adhesions. One of the major shortcomings of our study is the lack of a pre-application biochemical analysis of the COE obtained from an herbalist or knowledge of the region in Italy and the altitude where the COE we used originated. Since the content of many herbal agents can vary regionally and with altitude, precise information about these variables would enhance the value of future work. In summary, the COE reduced postoperative intra-abdominal adhesion formation but did not prevent it completely. The similarity of the results using HAAB and COE suggest that new agents should be investigated for this purpose. Further studies should also investigate the effectiveness of different quantities of COE. As predicted, COE reduced the development of adhesions, although it did not prevent them completely. Although our results show that COE is effective in preventing adhesions in rats, further studies are needed before it can be used in humans.

Ethics

Ethics Committee Approval: The study was approved by the Kahramanmaras Sutcu Imam University Local Ethics Committee (approval number: 2017/1-2 date: 03/01/2017). Informed Consent: Consent form was filled out by all participants.

Peer-review: Externally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: A.E., A.Y.B., A.I., A.N.S., A.O., M.A.I., Concept: A.E., M.S., A.N.S., Design: A.E., M.S., A.N.S., Data Collection or Processing: A.E., A.I., A.N.S., A.O., M.A.I., Analysis or Interpretation: A.E., I.T.K., O.A.E., A.Y.B., Literature Search: A.E., A.N.S., Writing: A.E., M.S., A.N.S.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

(1.) Parker MC, Ellis H, Moran BJ, Thompson JN, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O'Briena F, Buchan S, Crowe AM. Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum 2001;44:822-829.

(2.) Monk BJ, Berman ML, Montz FJ. Adhesions after extensive gynecologic surgery: clinical significance, etiology, and prevention. Am J Obstet Gynecol 1994;170:1396-1403.

(3.) Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O'Brien F, Buchan S, Crowe AM. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999;353:1476-1480.

(4.) Tingstedt B, Isaksson J, Andersson R. Long-term follow-up and cost analysis following surgery for small bowel obstruction caused by intra-abdominal adhesions. Br J Surg 2007;94:743-748.

(5.) Zhang G. Hyaluronic acid anti-adhesion barrier. Google Patents; 2003.

(6.) Zitterl-Eglseer K, Sosa S, Jurenitsch J, Schubert-Zsilavecz M, Della Loggia R, Tubaro A,Bertoldi M, Franz C. Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.). J Ethnopharmacol 1997;57:139-144.

(7.) Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69:1692-1696.

(8.) Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, Raam M, Daneshi S, Asadi-Yousefabad SL. Healing acceleration of acetic acid-induced colitis by marigold (Calendula officinalis) in male rats. Saudi J Gastroenterol 2016;22:50.

(9.) Sharp L, Finnila K, Johansson H, Abrahamsson M, Hatschek T, Bergenmar M. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial. Eur J Oncol Nurs 2013;17:429-435.

(10.) Parente LM, Lino Junior Rde S, Tresvenzol LM, Vinaud MC, de Paula JR, Paulo NM. Wound healing and anti-inflammatory effect in animal models of Calendula officinalis L. Growing in Brazil. Evid Based Complement Altern Med 2012;2012;375671.

(11.) Okuma CH, Andrade TA , Caetano GF, Finci LI, Maciel NR, Topan JF, Cefali LC, Polizello AC, Carlo T, Rogerio AP, Spadaro AC, Isaac VL, Frade MA, Rocha-Filho PA. Development of lamellar gel phase emulsion containing marigold oil (Calendula officinalis) as a potential modern wound dressing. Eur J Pharm Sci 2015;71:62-72.

(12.) Mishra AK, Mishra A, Verma A, Chattopadhyay P. Effects of calendula essential oil-based cream on biochemical parameters of skin of albino rats against ultraviolet B radiation. Sci Pharm 2012;80:669-683.

(13.) Mishra A, Mishra A, Chattopadhyay P. Assessment of in vitro sun protection factor of Calendula officinalis L.(asteraceae) essential oil formulation. J Young Pharm 2012;4:17-21.

(14.) Efstratiou E, Hussain AI, Nigam PS, Moore JE, Ayub MA, Rao JR. Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complement Ther Clin Pract 2012;18:173-176.

(15.) Dall'Acqua S, Catanzaro D, Cocetta V, Igl N, Ragazzi E, Giron MC, Cecconello L, Montopoli M. Protective effects of taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier. Fitoterapia 2016;109:230-235.

(16.) Carvalho AF de, Feitosa MC, Coelho NP, Rebelo VC, Castro JG, Sousa PR, Feitosa VC, Arisawa EA. Low-level laser therapy and Calendula officinalis in repairing diabetic foot ulcers. Rev Esc Enferm USP 2016;50:628-634.

(17.) Buzzi M, Freitas F d, Winter Mde B. Pressure ulcer healing with Plenusdermax[R] Calendula officinalis L. extract. Rev Bras Enferm 2016;69:250-257.

(18.) de Andrade M, Clapis MJ, do Nascimento TG, Gozzo Tde O, Almeida AM. Prevention of skin reactions due to teletherapy in women with breast cancer: a comprehensive review. Rev Lat Am Enfermagem 2012;20:604-611.

(19.) Akhoondinasab MR, Khodarahmi A, Akhoondinasab M, Saberi M, Iranpour M. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment. Burns 2015;41:125-131.

(20.) Bojadjiev C. On the sedative and hypotensive effect of preparations from the plant calendula officinalis. Nauchni Tr Vissh Med Inst Sofiia 1964;43:15-20.

(21.) Gol'dman II. [Anaphylactic shock after gargling with an infusion of Calendula]. Klin Med (Mosk) 1974;52:142-143.

(22.) Lagarto A, Bueno V, Guerra I, Valdes O, Vega Y, Torres L. Acute and subchronic oral toxicities of Calendula officinalis extract in Wistar rats. Exp Toxicol Pathol 2011;63:387-391.

(23.) Shipochliev T. [Uterotonic action of extracts from a group of medicinal plants]. Vet Med Nauki 1980;18:94-98.

(24.) Yilmaz HG, Tacyildiz IH, Keles C, Gedik E, Kilinc N. Micronized purified flavonoid fraction may prevent formation of intraperitoneal adhesions in rats. Fertil Steril 2005;84(Suppl 2):1083-1088.

(25.) Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl 1997:5-9.

(26.) Ha HK, Park CH, Kim SK, Chun CS, Kim IC, Lee HK, Shinn KS, Bahk YW. CT analysis of intestinal obstruction due to adhesions: early detection of strangulation. J Comput Assist Tomogr 1993;17:386-389.

(27.) McEntee G, Pender D, Mulvin D, McCullough M, Naeeder S, Farah S, Badurdeen MS, Ferraro V, Cham C, Gillham N, et al. Current spectrum of intestinal obstruction. Br J Surg 1987;74:976-980.

(28.) Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Van Goor H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000;87:467-471.

(29.) Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001;18:260-273.

(30.) Kennedy R, Costain DJ, McAlister VC, Lee TD. Prevention of experimental postoperative peritoneal adhesions by N,O-carboxymethyl chitosan. Surgery 1996;120:866-870.

(31.) Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol 2011;17:4545-4553.

(32.) Reijnen MM, Skrabut EM, Postma VA, Burns JW, van Goor H. Polyanionic polysaccharides reduce intra-abdominal adhesion and abscess formation in a rat peritonitis model. J Surg Res 2001;101:248-253.

(33.) Orcan S, Seven A, Isik H, Timur H, Caydere M, Ustun H, Batiloglu S. Resveratrol inhibits postoperative adhesion formation in a rat uterine horn adhesion model. Hum Fertil (Camb) 2012;15:217-220.

(34.) Oncel M, Remzi FH, Connor J, Fazio VW. Comparison of cecal abrasion and multiple-abrasion models in generating intra-abdominal adhesions for animal studies. Tech Coloproctol 2005;9:29-33.

(35.) Diamond MP, Linsky CB, Cunningham T, Constantine B, diZerega GS, DeCherney AH. A model for sidewall adhesions in the rabbit: reduction by an absorbable barrier. Microsurgery 1987;8:197-200.

(36.) Bakkum EA, Van Blitterswijk CA, Dalmeijer RA, Trimbos JB. A semiquantitative rat model for intraperitoneal postoperative adhesion formation. Gynecol Obstet Invest 1994;37:99-105.

(37.) Banasiewicz T, Horbacka K, Karon J, Malinger S, Antos F, Rudzki S, Kala Z, Stojcev Z, Kossi J, Krokowicz P. Preliminary study with SprayShieldTM Adhesion Barrier System in the prevention of abdominal adhesions. Videochir Inne Tech Maloinwazjne 2013;8:301-309.

(38.) Blauer KL, Collins RL. The effect of intraperitoneal progesterone on postoperative adhesion formation in rabbits. Fertil Steril 1988;49:144-149.

(39.) Hellebrekers BW, Trimbos-Kemper GC, Van Blitterswijk CA, Bakkum EA, Trimbos JB. Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Reprod 2000;15:1358-1363.

(40.) Emre A, Akin M, Isikgonul I, Yuksel O, Anadol AZ, Cifter C. Comparison of intraperitoneal honey and sodium hyaluronate-carboxymethylcellulose (SeprafilmTM) for the prevention of postoperative intra-abdominal adhesions. Clinics (Sao Pauso) 2009;64:363-368.

[iD] Arif Emre (1), [iD] Mehmet Sertkaya (2), [iD] Ali Isler (1), [iD] Abdulkadir Yasir Bahar (3), [iD] Ahmet Necati Sanli (1), [iD] Ali Ozkomec (1), [iD] Muhammed Ali Isik (4), [iD] Ilhami Taner Kale (1), [iD] Ozan Andac Erbil (5)

(1) Kahramanmaras Sutcu Imam University Faculty of Medicine, Department of General Surgery, Kahramanmaras, Turkey

(2) Viransehir State Hospital, Clinic of General Surgery, Sanliurfa, Turkey

(3) Kahramanmaras Sutcu Imam University Faculty of Medicine, Department of Medical Pathology, Kahramanmaras, Turkey

(4) Adiyaman University Faculty of Medicine, Department of General Surgery, Adiyaman, Turkey

(5) Gebze Fatih State Hospital, Clinic of General Surgery, Kocaeli, Turkey

Address for Correspondence/Yazisma Adresi: Arif Emre MD

Kahramanmaras Sutcu Imam University Faculty of Medicine, Department of General Surgery, Kahramanmaras, Turkey

Phone: +90 506 343 24 31 E-mail: dr.arifemre@gmail.com ORCID ID: orcid.org/0000-0002-6313-9742

Received/Gelis Tarihi: 01.03.2018 Accepted/Kabul Tarihi: 04.04.2018

DOI: 10.4274/tjcd.87059
Table 1. Macroscopic adhesion assessment scores for the three groups

Macroscopic findings          Calendula     Hyaluronic      Control
(Blauer and Collins           officinalis   acid            group
scale)                        extract       adhesion        (n=10)
                              group         barrier group
                              (n=10)        (n=10)

No adhesions                     2             3               -
Slender or narrow, easily        3             3               4
separable adhesions
Thick adhesions in a             3             1               2
limited area
Widespread thick                 2             3               1
adhesions
Widespread thick                                               3
adhesions connecting
organs with the anterior or
posterior abdominal wall
Total                           10            10              10

Table 2. Scores for adhesions in the three groups based on macro- and
microscopic findings

Group                     n            Microscopy       Macroscopy
                                       Median           Median
                                       (range)          (range)

Control                   10           0.5 (0-2)        1.5 (0-3)
Hyaluronic acid           10           1 (1-3)          1 (0-3)
Calendula officinalis     10           2 (1-2)          2 (1-4)
Total                     30           1 (0-3)          1.5 (0-4)
p values (overall)                     0.004            0.266
                          I&II         0.044            ns
Pairwise                  I&III        0.010            ns
comparisons
                          II&III       1                ns

Kruskal-Wallis test (Monte Carlo), Dunn's post hoc test ns: Not
significant

Table 3. Microscopic adhesion assessment scores in the three groups

Microscopy findings           Calendula       Hyaluronic      Control
                              officinalis     acid adhesion   group
                              gr[degrees]Up   barrier group

No inflammation                    5               -               -
Large cells, rare scattered        4               6               4
lymphocytes and plasma
cells
Large cells together with          1               3               6
an increased number of
lymphocytes, neutrophils,
eosinophils, and plasma
cells
Multiple and mixed                 -               1               -
inflammatory cells,
micro-abscesses
Total                             10              10              10
COPYRIGHT 2018 Galenos Yayinevi Tic. Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RESEARCH ARTICLE
Author:Emre, Arif; Sertkaya, Mehmet; Isler, Ali; Bahar, Abdulkadir Yasir; Sanli, Ahmet Necati; Ozkomec, Ali
Publication:Turkish Journal of Colorectal Disease
Article Type:Report
Date:Jun 1, 2018
Words:3641
Previous Article:Depression, Anxiety, Sexual Dysfunction and Quality of Life in Patients with Ileostomy or Colostomy/Ileostomi veya Kolostomisi Olan Hastalarin...
Next Article:Episiotomy-Related Perineal Injury During Spontaneous Vaginal Delivery/Normal Dogum Sirasinda Epizyotomiye Bagli Perine Yaralanmasi.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters